US7601758 — Methods for concomitant administration of colchicine and macrolide antibiotics in the treatment of gout flares
Method of Use · Assigned to Mutual Pharmaceutical Co Inc · Expires 2029-02-10 · 3y remaining
What this patent protects
This patent protects methods for treating gout flares by concomitantly administering colchicine with one or more macrolide antibiotics.
USPTO Abstract
Methods for treating gout flares comprising concomitant administration of colchicine together with one or more macrolide antibiotics, e.g., clarithromycin or erythromycin, are disclosed. Such methods reduce the dangers commonly associated with such concomitant administration and provide additional benefits. Methods of notifying health care practitioners and patients regarding appropriate dosing for co-administration of colchicine together with macrolide antibiotics are also provided.
Drugs covered by this patent
- Colcrys (COLCHICINE) · Scilex Pharms
FDA Patent Use Codes
When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.
| Code | Description | Drug |
|---|---|---|
U-1007 |
— | Colcrys |
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.